← brief for 2026-10-17 · Slowing decline

A gentler squeeze: A first signal from OCE-205, a selective V1a mixed agonist–antagonist for hepatorenal syndrome–acute kidney injury

Article No results yet Peer reviewed

Key takeaways

This article discusses a new drug called OCE-205 for liver and kidney failure. It shares early signals from testing but does not provide full results yet. The study is still in progress.

Who did this work

Prowpanga Udompap (Minneapolis VA Health Care System)

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-16
https://doi.org/10.1097/hep.0000000000001851